Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.62 |
| ▸ | EGFR | P00533 | 4/20 | 0.59 |
| ▸ | JAK2 | O60674 | 3/20 | 0.55 |
| ▸ | FLT3 | P36888 | 2/20 | 0.55 |
| ▸ | CDK2 | P24941 | 2/20 | 0.53 |
| ▸ | JAK3 | P52333 | 1/20 | 0.53 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.53 |
| ▸ | CDK4 | P11802 | 4/20 | 0.53 |
| ▸ | AURKA | O14965 | 2/20 | 0.53 |
| ▸ | KDR | P35968 | 3/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | BRD4 | O60885 | 1/20 | 0.50 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.49 |
| ▸ | FLT4 | P35916 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20012916 | 0.81 | JAK2 (0.60) | EGFRJAK2FLT3CDK2CDK4 | |
| SCHEMBL20012912 | 0.80 | ALK (0.62) | EGFRJAK2FLT3CDK2JAK3 | |
| SCHEMBL20012950 | 0.80 | AURKA (0.54) | EGFRJAK2FLT3CDK4AURKA | |
| SCHEMBL20012904 | 0.80 | CDK4 (0.54) | MKNK1EGFRJAK2CDK2CCNE1 | |
| SCHEMBL20012911 | 0.80 | EGFR (0.57) | MKNK1EGFRJAK2CDK4AURKA | |
| SCHEMBL27020409 | 0.79 | EGFR (0.64) | MKNK1EGFRJAK2FLT3CDK2 | |
| SCHEMBL27654819 | 0.79 | MAPT (0.56) | MKNK1EGFRCDK2AURKAKDR | |
| SCHEMBL30306480 | 0.78 | EGFR (0.60) | MKNK1EGFRJAK2FLT3CDK2 | |
| SCHEMBL12325149 | 0.78 | BRD4 (0.64) | MKNK1EGFRJAK2CDK2JAK3 | |
| SCHEMBL20012983 | 0.78 | EGFR (0.54) | EGFRJAK2FLT3CDK4AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018056621-A1 | NOVEL IMIDAZOLYL PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 재단법인 대구경북첨단의료산업진흥재단 | 2018-03-29 | — | — | WO | disclosed |